[State of physiological anticoagulant heparin, antithrombin III and their correction with medicines in patients with acute viral myocarditis].
For the first time, positive influence was shown of a complex blood heparin-antitrombin III on the state of the coagulant and fibrinolytic system of blood in patients with acute virus myocarditis that favours the normalization of clinical and laboratory indicators, improvement of the state of patients and reduction of average bed-day indicator (hospital stay) till 25 and 35 days in accordance with severity of clinical course of the disease and can be recommended as a choice of medicine.
Doroshenko
B H
BH
Saliuta
M Iu
MIu
Nazar
P S
PS
Kotko
D M
DM
Karpenko
O I
OI
Bezuhlova
S V
SV
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000990:Antithrombin III / Q000032:analysis* / Q000502:physiology; D001777:Blood Coagulation / Q000502:physiology*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006493:Heparin / Q000097:blood* / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D009205:Myocarditis / Q000097:blood* / Q000628:therapy / Q000821:virology; D010951:Plasma Exchange; D012720:Severity of Illness Index; D014777:Virus Diseases / Q000097:blood* / Q000628:therapy; D055815:Young Adult
D000990:Antithrombin III; D006493:Heparin